Hernández-Martínez, P <br/><br/>
Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma.  [electronic resource] 

 -  Archivos de la Sociedad Espanola de Oftalmologia  Aug 2015 
 - 399-401 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1989-7286 
<br/><br/><label>Standard No.: </label>10.1016/j.oftal.2014.01.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenergic beta-Antagonists--administration & dosage<br/>Adult<br/>Angiogenesis Inhibitors--administration & dosage<br/>Combined Modality Therapy<br/>Drug Therapy, Combination<br/>Hemangioblastoma--complications<br/>Humans<br/>Intravitreal Injections<br/>Laser Coagulation<br/>Male<br/>Propranolol--administration & dosage<br/>Ranibizumab--administration & dosage<br/>Recurrence<br/>Retinal Detachment--drug therapy<br/>Retinal Neoplasms--complications